This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by To, K. K. W.
Right arrow Articles by Bates, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by To, K. K. W.
Right arrow Articles by Bates, S. E.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, November 2006, p. 8572-8585, Vol. 26, No. 22
0270-7306/06/$08.00+0     doi:10.1128/MCB.00650-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Aberrant Promoter Methylation of the ABCG2 Gene in Renal Carcinoma{triangledown}

Kenneth K. W. To,* Z. Zhan, and Susan E. Bates

Experimental Therapeutics Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892

Received 14 April 2006/ Returned for modification 2 June 2006/ Accepted 28 August 2006

ABCG2 is a ubiquitous ATP-binding cassette transmembrane protein that is important in clinical drug resistance. Little is known about the mechanism(s) regulating the expression of ABCG2. We hypothesized that DNA methylation could play a role in the epigenetic regulation of ABCG2 gene expression. The promoter methylation status of three renal carcinoma cell lines was assessed with restriction enzyme digestion-coupled PCR and bisulfite genomic sequencing. Both UOK121 and UOK143, with known methylation of the VHL promoter, showed induction of ABCG2 expression after 5-aza-2'-deoxycytidine (5-aza-dC) treatment, suggesting that aberrant methylation of the ABCG2 gene was associated with gene silencing. In vitro methylation of the ABCG2 promoter-driven luciferase reporter vector resulted in a significant inhibition of transcription. Our data suggested that the ABCG2 gene is regulated coordinately at both histone and DNA levels. A chromatin immunoprecipitation assay demonstrated that the methylated promoter in UOK121 and UOK143, but not the unmethylated one in UOK181, is associated with the methyl CpG binding domain proteins (MBDs), MBD2 and MeCP2. Histone deacetylase 1 and a corepressor, mSin3A, were identified binding to the promoter region containing the CpG island, thereby suppressing ABCG2 transcription. Reactivation of ABCG2 was achieved by treatment with 5-aza-dC, a demethylating agent, concomitant with the release of MBDs from the promoter. Furthermore, the association of methylated lysine 9 on histone H3, a hallmark of promoter methylation, with the promoter was reduced following 5-aza-dC treatment. These data suggest that DNA methylation-dependent formation of a repressor complex in the CpG island contributes to inactivation of ABCG2.

* Corresponding author. Mailing address: Experimental Therapeutics Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bldg. 10, Room 13N220, 10 Center Dr., Bethesda, MD 20892-4255. Phone: (301) 496-0795. Fax: (301) 402-1608. E-mail: tok{at}mail.nih.gov.

{triangledown} Published ahead of print on 5 September 2006.

Molecular and Cellular Biology, November 2006, p. 8572-8585, Vol. 26, No. 22
0270-7306/06/$08.00+0     doi:10.1128/MCB.00650-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pan, Y.-Z., Morris, M. E., Yu, A.-M. (2009). MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells. Mol. Pharmacol. 75: 1374-1379 [Abstract] [Full Text]  
  • Hauswald, S., Duque-Afonso, J., Wagner, M. M., Schertl, F. M., Lubbert, M., Peschel, C., Keller, U., Licht, T. (2009). Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes. Clin. Cancer Res. 15: 3705-3715 [Abstract] [Full Text]  
  • Lemos, C., Kathmann, I., Giovannetti, E., Belien, J. A.M., Scheffer, G. L., Calhau, C., Jansen, G., Peters, G. J. (2009). Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins. Molecular Cancer Therapeutics 8: 655-664 [Abstract] [Full Text]  
  • Cui, L., Xu, L.-Y., Shen, Z.-Y., Tao, Q., Gao, S.-Y., Lv, Z., Du, Z.-P., Fang, W.-K., Li, E.-M. (2008). NGALR Is Overexpressed and Regulated by Hypomethylation in Esophageal Squamous Cell Carcinoma. Clin. Cancer Res. 14: 7674-7681 [Abstract] [Full Text]  
  • To, K. K. W., Zhan, Z., Litman, T., Bates, S. E. (2008). Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line. Mol. Cell. Biol. 28: 5147-5161 [Abstract] [Full Text]  
  • Poonkuzhali, B., Lamba, J., Strom, S., Sparreboom, A., Thummel, K., Watkins, P., Schuetz, E. (2008). Association of Breast Cancer Resistance Protein/ABCG2 Phenotypes and Novel Promoter and Intron 1 Single Nucleotide Polymorphisms. Drug Metab. Dispos. 36: 780-795 [Abstract] [Full Text]  
  • Wang, H., Lee, E.-W., Zhou, L., Leung, P. C. K., Ross, D. D., Unadkat, J. D., Mao, Q. (2008). Progesterone Receptor (PR) Isoforms PRA and PRB Differentially Regulate Expression of the Breast Cancer Resistance Protein in Human Placental Choriocarcinoma BeWo Cells. Mol. Pharmacol. 73: 845-854 [Abstract] [Full Text]  
  • To, K. K.W., Polgar, O., Huff, L. M., Morisaki, K., Bates, S. E. (2008). Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells. Mol Cancer Res 6: 151-164 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»